Amped Up Politics and the Future of Central Banking

Related Link: 

Investors should watch for any further deterioration in relations between politicians and central bankers; monetary policy is at a critical juncture.

BAT Agrees to Pay $49 Billion for Full Control of Reynolds

Related Link: 

British American Tobacco and Reynolds American said they had agreed to a sweetened offer of $49.4 billion from BAT for the 57.8% of Reynolds that it doesn’t already own.

Lenovo Thought It Knew How to Fix Brands---Then It Bought Motorola

Related Link: 

Success with a deal for IBM personal computers led China’s Lenovo to underestimate the difficulty of reviving smartphone company Motorola Mobility. “We underestimated the differences of the culture and the business model,” says the CEO.

Fed Officials See Less Need for Government Stimulus

Related Link: 

Federal Reserve officials increasingly say they don’t see a need for stimulative government tax and spending programs to boost short-term economic growth, reversing their stance during and after the Great Recession.

Trump Warns on House GOP Tax Plan

Related Link: 

Donald Trump criticized a cornerstone of House Republicans’ corporate-tax plan, which they had pitched as an alternative to his proposed import tariffs, creating another point of contention between the incoming president and congressional allies.

Prosecutors' Pursuit of Heir Threatens Samsung's Stability

Related Link: 

Prosecutors’ decision to seek the arrest of Samsung Group heir Lee Jae-yong threatens to knock one of the world’s biggest companies off course—and, represents a significant challenge to South Korea’s large, family-run companies.

Appointment of Trump's Economic Policy Team Faces Delays

Related Link: 

Several of Donald Trump’s top economic policy jobs may go unfilled for days or even weeks after he is sworn in, potentially slowing his pursuit of an ambitious domestic policy agenda.

A Delicate Balancing Act: Rewarding Voters While Preserving Growth

Related Link: 

Will antiestablishment leaders, once in power, reward the people and regions that backed them at the expense of more dynamic regions and industries, hobbling economic growth?

Big Pharma's Newest Headache: Rival Drugmakers

Related Link: 

The world’s best-selling drugs face new competition.

Italy's Downgrade Is No Buying Opportunity

Related Link: 

Instead, the cut by DBRS serves as a further reminder of the structural problems the country’s economy faces.

Syndicate content